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www.jacc-interventions.org to view.Biomechanical Modeling to Improve Coronary Artery Bifurcation Stenting:
Expert Review Document on Techniques and Clinical Implementation1281Antonios P. Antoniadis, Peter Mortier, Ghassan Kassab, Gabriele Dubini, Nicolas Foin,
Yoshinobu Murasato, Andreas A. Giannopoulos, Shengxian Tu, Kiyotaka Iwasaki,
Yutaka Hikichi, Francesco Migliavacca, Claudio Chiastra, Jolanda J. Wentzel, Frank Gijsen,
Johan H.C. Reiber, Peter Barlis, Patrick W. Serruys, Deepak L. Bhatt, Goran Stankovic,
Elazer R. Edelman, George D. Giannoglou, Yves Louvard, Yiannis S. ChatzizisisBifurcation lesions are common targets of percutaneous coronary interventions. Local ﬂow conditions
determine the localization, progression, and clinical outcomes of atherosclerosis in coronary
bifurcations. Computational simulations and in vitro bench testing of stent mechanical properties
and local hemodynamic patterns pre- and post-stenting can help toward better percutaneous
treatment of bifurcation lesions and optimization of stenting techniques and stent design.CORONARY Long-Term Clinical Outcomes of Final Kissing Ballooning in Coronary Bifurcation Lesions
Treated With the 1-Stent Technique: Results From the COBIS II Registry
(Korean Coronary Bifurcation Stenting Registry)1297Cheol Woong Yu, Jeong Hoon Yang, Young Bin Song, Joo-Yong Hahn, Seung-Hyuk Choi,
Jin-Ho Choi, Hyun Jong Lee, Ju Hyeon Oh, Bon-Kwon Koo, Seung Woon Rha,
Jin-Ok Jeong, Myung-Ho Jeong, Jung Han Yoon, Yangsoo Jang, Seung-Jea Tahk,
Hyo-Soo Kim, Hyeon-Cheol GwonThe association of ﬁnal kissing ballooning with clinical and angiographic outcomes after only main
vessel stenting is undeﬁned, although ﬁnal kissing ballooning is currently considered mandatory in
2-stent techniques. In a large, multicenter Korean registry trial studying coronary bifurcation
lesions, the 1-stent technique with ﬁnal kissing ballooning was associated with favorable long-term
clinical outcome, mainly driven by the reduction of target lesion revascularization in the main vessel
or both vessels as a result of an increase in minimal luminal diameter.CONTINUED ON PAGE A-14
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AUGUST 24, 2015 VOLUME 8, NUMBER 10Comparative Analysis of Sequential Proximal Optimizing Technique Versus
Kissing Balloon Inﬂation Technique in Provisional Bifurcation Stenting:
Fractal Coronary Bifurcation Bench Test1308Gérard Finet, François Derimay, Pascal Motreff, Patrice Guerin, Paul Pilet,
Jacques Ohayon, Olivier Darremont, Gilles RioufolIn provisional bifurcation stenting, kissing balloon inﬂation (KBI) has shown no clinical beneﬁt, at the
cost of adverse effects induced by oblong proximal deformation caused by juxtaposing the 2
balloons. The present study used a fractal bifurcation bench model to compare 6 provisional
stenting optimization sequences, including 1 called “re-POT,” with no KBI and associating initial
proximal optimizing technique (POT) plus side-branch inﬂation and ﬁnal POT. In comparison with 5
other techniques, re-POT signiﬁcantly optimized outcome, maintaining circular geometry while
signiﬁcantly reducing side branch ostium strut obstruction and global strut malapposition.
Differential Prognostic Effect Between First- and Second-Generation Drug-Eluting
Stents in Coronary Bifurcation Lesions: Patient-Level Analysis of the
Korean Bifurcation Pooled Cohorts1318Joo Myung Lee, Joo-Yong Hahn, Jeehoon Kang, Kyung Woo Park, Woo Jung Chun,
Seung Woon Rha, Cheol Woong Yu, Jin-Ok Jeong, Myung-Ho Jeong, Jung Han Yoon,
Yangsoo Jang, Seung-Jea Tahk, Hyeon-Cheol Gwon, Bon-Kwon Koo, Hyo-Soo KimPatient-level pooled analysis of 3,162 patients in Korean Bifurcation Pooled Cohorts demonstrated
the differential prognostic effect of a 2-stenting strategy between ﬁrst- and second-generation
drug-eluting stents (DES) from the largest real-world population who underwent bifurcation
percutaneous coronary intervention (PCI). The 2-stenting technique using second-generation DES
showed comparable clinical outcomes, including stent thrombosis, target lesion revascularization,
myocardial infarction, and mortality up to 3-year follow-up, compared with the 1-stenting
technique. In real-world practice of bifurcation PCI with second-generation DES, independent
predictors of clinical outcomes were all patient-related comorbidities, not procedure-related
factors such as 1- or 2-stenting techniques.
SEE ADDITIONAL CONTENT ONLINEn EDITORIAL COMMENT
Current Treatment of Bifurcation Lesions: Re-Examining the 1- Versus 2-Stent Argument 1332
Aaron V. KaplanCONTINUED ON PAGE A-15
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AUGUST 24, 2015 VOLUME 8, NUMBER 10Clinical Outcome After DK Crush Versus Culotte Stenting of Distal Left Main
Bifurcation Lesions: The 3-Year Follow-Up Results of the DKCRUSH-III Study1335Shao-Liang Chen, Bo Xu, Ya-Ling Han, Imad Sheiban, Jun-Jie Zhang, Fei Ye,
Tak W. Kwan, Chitprapai Paiboon, Yu-Jie Zhou, Shu-Zheng Lv, George D. Dangas,
Ya-Wei Xu, Shang-YuWen, Lang Hong, Rui-Yan Zhang, Hai-ChangWang, Tie-Ming Jiang,
Yan Wang, Teguh Sansoto, Fang Chen, Zu-Yi Yuan, Wei-Min Li, Martin B. LeonA total of 419 patients with left main distal bifurcation lesions (LMDBLs) were randomly assigned to
either the double-kissing or culotte stenting group. Culotte stenting was associated with more
frequent major adverse cardiac events at 3 years compared with the double-kissing group.
Complex LMDBLs stratiﬁed by the DEFINITION (Deﬁnition and Impact of Complex Bifurcation
Lesions on Clinical Outcomes After Percutaneous Coronary Intervention Using Drug-Eluting Stents)
study criteria had higher 3-year major adverse cardiac event rates, particularly after culotte stenting.n EDITORIAL COMMENT
Unmatched Results After Double Kissing Crush Stenting Technique in
Distal Left Main Coronary Artery Treatment?1343Leif Thuesen, Niels Ramsing HolmSTRUCTURAL Baseline Characteristics and Prognostic Implications of Pre-Existing and
New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation:
Results From the FRANCE-2 Registry1346Romain Chopard, Emmanuel Teiger, Nicolas Meneveau, Sidney Chocron, Martine Gilard,
Marc Laskar, Hélène Eltchaninoff, Bernard Iung, Pascal Leprince, Karine Chevreul,
Alain Prat, Michel Lievre, Alain Leguerrier, Patrick Donzeau-Gouge, Jean Fajadet,
Gauthier Mouillet, Francois Schiele, for the FRANCE-2 InvestigatorsThe impact of pre-existing and new-onset atrial ﬁbrillation (AF) is unknown. The FRANCE-2 registry
included 3,933 patients undergoing transcatheter aortic valve implantation (TAVI) in France in 2010
to 2011. AF was documented before TAVI in 25.8%. New-onset AF was observed in 6% after TAVI. At
1 year, death rate, rehospitalization for worsening heart failure, and New York Heart Association
functional class were signiﬁcantly higher among patients with pre-existing AF versus those
without. New-onset AF in patients without pre-existing AF was associated with a higher rate of
combined safety endpoint at 30 days and a higher rate of both all-cause death and combined
efﬁcacy endpoint at 1 year.
SEE ADDITIONAL CONTENT ONLINEn EDITORIAL COMMENT
Atrial Fibrillation and Transcatheter Aortic Valve Replacement:
The Burden of Advanced Cardiovascular Disease in Aortic Stenosis1356Jonathon M. White, Susheel K. KodaliCONTINUED ON PAGE A-16
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AUGUST 24, 2015 VOLUME 8, NUMBER 10Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable
Supra-Annular Self-Expanding Transcatheter Aortic Valve System1359Ganesh Manoharan, Antony S. Walton, Stephen J. Brecker, Sanjeevan Pasupati,
Daniel J. Blackman, Hongyan Qiao, Ian T. MeredithThis prospective single-arm, multicenter pivotal study was designed to evaluate the safety and
clinical performance of the novel, repositionable, 14-F equivalent CoreValve Evolut R TAVR system
(Medtronic, Inc., Minneapolis, Minnesota) in high- or extreme-risk patients. A total of 60 patients
(mean age 82.8  6.1 years; Society of Thoracic Surgeons Score: 7.0  3.7%) were successfully
treated with a 26- or 29-mm Evolut R valve. No death or stroke was observed up to 30 days.
Repositioning (n ¼ 22) was successful when required in all patients, with low rates of moderate
(3.4%) or severe (0.0%) paravalvular aortic regurgitation and of permanent pacemaker
implantation (11.7%).
SEE ADDITIONAL CONTENT ONLINEPERIPHERAL Stent Repair for Complex Coarctation of Aorta 1368
José Suárez de Lezo, Miguel Romero, Manuel Pan, Javier Suárez de Lezo, José Segura,
Soledad Ojeda, Djordje Pavlovic, Francisco Mazuelos, José López Aguilera,
Simona Espejo PerezThis study analyzed our 21-year experience in the percutaneous treatment of complex coarctation of
aorta in 60 patients (mean age 24  16 years). The following adverse conditions for treatment were
observed: complete interruption of the aortic arch; associated aneurysm; complex stenosis; or the
need for stent re-expansion. Two patients had died by 1-month follow-up. All remaining patients
did well and were followed-up for a mean period of 10  6 years. Late adverse events occurred in
3 patients. The remaining 55 patients are symptom-free with normal baseline blood pressure. The
actuarial survival-free probability of all complex patients at 15 years was 92%.n EDITORIAL COMMENT
Overcoming Complexity: Stenting for Aortic Coarctation Comes of Age 1380
Damien P. Kenny, Ziyad M. HijaziCONTINUED ON PAGE A-17
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AUGUST 24, 2015 VOLUME 8, NUMBER 10A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed,
Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism:
The SEATTLE II Study
1382Gregory Piazza, Benjamin Hohlfelder, Michael R. Jaff, Kenneth Ouriel,
Tod C. Engelhardt, Keith M. Sterling, Noah J. Jones, John C. Gurley, Rohit Bhatheja,
Robert J. Kennedy, Nilesh Goswami, Kannan Natarajan, John Rundback,
Immad R. Sadiq, Stephen K. Liu, Narinder Bhalla, M. Laiq Raja, Barry S. Weinstock,
Jacob Cynamon, Fakhir F. Elmasri, Mark J. Garcia, Mark Kumar, Juan Ayerdi,
Peter Soukas, William Kuo, Ping-Yu Liu, Samuel Z. Goldhaber,
for the SEATTLE II InvestigatorsUse of systemic ﬁbrinolysis for acute pulmonary embolism (PE) is limited by the risk of hemorrhagic
stroke. Piazza et al. evaluated the safety and efﬁcacy of ultrasound-facilitated, catheter-directed
ﬁbrinolysis. Eligible patients had a proximal PE and a right ventricular (RV)-to-left ventricular
(LV)–diameter ratio $0.9 on chest computed tomography. This study included 150 patients with
acute massive or submassive PE. The mean RV/LV diameter ratio decreased by 25% from baseline
to 48 h post-procedure. Major bleeding occurred in 10% of patients. No patient experienced
intracranial hemorrhage. Ultrasound-facilitated, catheter-directed ﬁbrinolysis decreased RV
dilation and minimized intracranial hemorrhage in patients with acute massive and submassive PE.
SEE ADDITIONAL CONTENT ONLINEn EDITORIAL COMMENT
Catheter-Directed Thrombolysis for Pulmonary Embolism: Where Do We Stand? 1393
Akhilesh K. Sista, Clive KearonIMAGES IN
INTERVENTIONPercutaneous Coronary Artery Bypass for Type 3 Coronary Perforation 1396
Shingo Yamamoto, Kenichi Sakakura, Hiroshi Funayama, Hiroshi Wada, Hideo Fujita,
Shin-ichi Momomura
First-In-Man Simultaneous Transcatheter Aortic and Mitral Valve Replacement to
Treat Severe Native Aortic and Mitral Valve Stenoses1399Adam Witkowski, Krzysztof Kusmierski, Zbigniew Chmielak, Maciej Da˛browski,
Jan Jastrzębski, Ilona Michałowska, Tomasz Hryniewiecki, Piotr SzymanskiCONTINUED ON PAGE A-18
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AUGUST 24, 2015 VOLUME 8, NUMBER 10n ONLINE FEATURE Transcatheter Aortic and Mitral Valve Replacement in a
Patient With Critical Aortic and Mitral Valve In-Ring Stenosise155Ricardo Yaryura, Atiq Rehman, Hakim Morsli, Nasir Hussain
n ONLINE FEATURE Late Presentation of Left Main Coronary Artery Impingement
Post-Transcatheter Aortic Valve Replacemente159Peter Lugomirski, Brian McArdle, Aiman Alak, Alexander Dick, Marino Labinaz
n ONLINE FEATURE First-in-Human Transcatheter Pulmonic Valve Implantation
Through a Tricuspid Valve Bioprosthesis to Treat Native Pulmonary Valve Regurgitation
Caused by Carcinoid Syndromee161Manoj Kesarwani, Thomas A. Ports, Rajni K. Rao, Vaikom S. Mahadevan
n ONLINE FEATURE “DVT” of the Heart: A “Novel” Treatment for an Old Problem e165
Naga Venkata Pothineni, Amit Bahia, Freij Gobal, Zubair Ahmed, Barry F. Uretsky,
Abdul Hakeem
n ONLINE FEATURE Development of Late Stent Malapposition After
Paclitaxel-Coated Balloon Angioplasty for In-Stent Neoatherosclerosise167Kazuhiko Yumoto, Takahiro Watanabe, Tomoyuki Fukuzawa, Yuichi Hanaki,
Hajime Aoki, Kenichi Kato
n ONLINE FEATURE Late Structural Discontinuity as a Possible Cause of
Very Late Everolimus-Eluting Bioresorbable Scaffold Thrombosise171Alfonso Ielasi, Bernardo Cortese, Giuseppe Steffenino
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